Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and Costs
April 18th 2016Real-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.
Read More
2 Commerce Drive
Cranbury, NJ 08512